nodes	percent_of_prediction	percent_of_DWPC	metapath
Palonosetron—Electrocardiogram T wave amplitude decreased—Varenicline—nicotine dependence	0.268	0.297	CcSEcCtD
Palonosetron—Joint stiffness—Varenicline—nicotine dependence	0.0535	0.0593	CcSEcCtD
Palonosetron—Platelet count decreased—Varenicline—nicotine dependence	0.0271	0.0301	CcSEcCtD
Palonosetron—HTR3A—Ligand-gated ion channel transport—GABRA4—nicotine dependence	0.023	0.233	CbGpPWpGaD
Palonosetron—Glycosuria—Varenicline—nicotine dependence	0.0199	0.0221	CcSEcCtD
Palonosetron—Eye irritation—Varenicline—nicotine dependence	0.0189	0.021	CcSEcCtD
Palonosetron—Ventricular extrasystoles—Varenicline—nicotine dependence	0.0179	0.0198	CcSEcCtD
Palonosetron—Hyperkalaemia—Varenicline—nicotine dependence	0.0159	0.0176	CcSEcCtD
Palonosetron—Influenza like illness—Varenicline—nicotine dependence	0.0157	0.0174	CcSEcCtD
Palonosetron—Salivary hypersecretion—Varenicline—nicotine dependence	0.0157	0.0174	CcSEcCtD
Palonosetron—Euphoric mood—Varenicline—nicotine dependence	0.0139	0.0154	CcSEcCtD
Palonosetron—Hot flush—Varenicline—nicotine dependence	0.0125	0.0139	CcSEcCtD
Palonosetron—Menopausal symptoms—Varenicline—nicotine dependence	0.0124	0.0138	CcSEcCtD
Palonosetron—Urinary retention—Varenicline—nicotine dependence	0.0111	0.0124	CcSEcCtD
Palonosetron—Abdominal pain upper—Varenicline—nicotine dependence	0.0107	0.0119	CcSEcCtD
Palonosetron—Hypokalaemia—Varenicline—nicotine dependence	0.0107	0.0118	CcSEcCtD
Palonosetron—Gastritis—Varenicline—nicotine dependence	0.0104	0.0115	CcSEcCtD
Palonosetron—Abdominal distension—Varenicline—nicotine dependence	0.0102	0.0113	CcSEcCtD
Palonosetron—CYP2D6—CYP2E1 reactions—CYP2A7—nicotine dependence	0.00956	0.097	CbGpPWpGaD
Palonosetron—Hyperglycaemia—Varenicline—nicotine dependence	0.00914	0.0101	CcSEcCtD
Palonosetron—Hepatobiliary disease—Varenicline—nicotine dependence	0.00854	0.00947	CcSEcCtD
Palonosetron—Epistaxis—Varenicline—nicotine dependence	0.00852	0.00945	CcSEcCtD
Palonosetron—Sinusitis—Varenicline—nicotine dependence	0.00847	0.0094	CcSEcCtD
Palonosetron—Bradycardia—Varenicline—nicotine dependence	0.00825	0.00916	CcSEcCtD
Palonosetron—Urinary tract disorder—Varenicline—nicotine dependence	0.00801	0.00888	CcSEcCtD
Palonosetron—Connective tissue disorder—Varenicline—nicotine dependence	0.00797	0.00884	CcSEcCtD
Palonosetron—Urethral disorder—Varenicline—nicotine dependence	0.00795	0.00882	CcSEcCtD
Palonosetron—Eye disorder—Varenicline—nicotine dependence	0.00758	0.0084	CcSEcCtD
Palonosetron—Tinnitus—Varenicline—nicotine dependence	0.00756	0.00838	CcSEcCtD
Palonosetron—Cardiac disorder—Varenicline—nicotine dependence	0.00752	0.00835	CcSEcCtD
Palonosetron—CYP2D6—Fatty acids—CYP2A7—nicotine dependence	0.00746	0.0757	CbGpPWpGaD
Palonosetron—Angiopathy—Varenicline—nicotine dependence	0.00736	0.00816	CcSEcCtD
Palonosetron—Immune system disorder—Varenicline—nicotine dependence	0.00732	0.00812	CcSEcCtD
Palonosetron—Mediastinal disorder—Varenicline—nicotine dependence	0.00731	0.00811	CcSEcCtD
Palonosetron—Chills—Varenicline—nicotine dependence	0.00727	0.00807	CcSEcCtD
Palonosetron—Arrhythmia—Varenicline—nicotine dependence	0.00724	0.00803	CcSEcCtD
Palonosetron—Mental disorder—Varenicline—nicotine dependence	0.0071	0.00788	CcSEcCtD
Palonosetron—Erythema—Varenicline—nicotine dependence	0.00706	0.00783	CcSEcCtD
Palonosetron—Malnutrition—Varenicline—nicotine dependence	0.00706	0.00783	CcSEcCtD
Palonosetron—Flatulence—Varenicline—nicotine dependence	0.00695	0.00771	CcSEcCtD
Palonosetron—Dysgeusia—Varenicline—nicotine dependence	0.00691	0.00767	CcSEcCtD
Palonosetron—Anaemia—Varenicline—nicotine dependence	0.00652	0.00724	CcSEcCtD
Palonosetron—Convulsion—Varenicline—nicotine dependence	0.00611	0.00678	CcSEcCtD
Palonosetron—Hypertension—Varenicline—nicotine dependence	0.00609	0.00676	CcSEcCtD
Palonosetron—Myalgia—Varenicline—nicotine dependence	0.00601	0.00667	CcSEcCtD
Palonosetron—Arthralgia—Varenicline—nicotine dependence	0.00601	0.00667	CcSEcCtD
Palonosetron—Anxiety—Varenicline—nicotine dependence	0.00599	0.00664	CcSEcCtD
Palonosetron—Unspecified disorder of skin and subcutaneous tissue—Varenicline—nicotine dependence	0.00597	0.00662	CcSEcCtD
Palonosetron—Discomfort—Varenicline—nicotine dependence	0.00594	0.00659	CcSEcCtD
Palonosetron—CYP2D6—Xenobiotics—CYP2A7—nicotine dependence	0.00593	0.0602	CbGpPWpGaD
Palonosetron—Dry mouth—Varenicline—nicotine dependence	0.00588	0.00652	CcSEcCtD
Palonosetron—Infection—Varenicline—nicotine dependence	0.00572	0.00635	CcSEcCtD
Palonosetron—Shock—Varenicline—nicotine dependence	0.00567	0.00629	CcSEcCtD
Palonosetron—Nervous system disorder—Varenicline—nicotine dependence	0.00565	0.00627	CcSEcCtD
Palonosetron—Tachycardia—Varenicline—nicotine dependence	0.00562	0.00624	CcSEcCtD
Palonosetron—Skin disorder—Varenicline—nicotine dependence	0.00559	0.00621	CcSEcCtD
Palonosetron—Anorexia—Varenicline—nicotine dependence	0.00549	0.00609	CcSEcCtD
Palonosetron—Hypotension—Varenicline—nicotine dependence	0.00538	0.00597	CcSEcCtD
Palonosetron—Musculoskeletal discomfort—Varenicline—nicotine dependence	0.00525	0.00582	CcSEcCtD
Palonosetron—Insomnia—Varenicline—nicotine dependence	0.00521	0.00578	CcSEcCtD
Palonosetron—Dyspnoea—Varenicline—nicotine dependence	0.00513	0.0057	CcSEcCtD
Palonosetron—Somnolence—Varenicline—nicotine dependence	0.00512	0.00568	CcSEcCtD
Palonosetron—Dyspepsia—Varenicline—nicotine dependence	0.00507	0.00562	CcSEcCtD
Palonosetron—CYP1A2—Xenobiotics—CYP2A7—nicotine dependence	0.00502	0.051	CbGpPWpGaD
Palonosetron—Decreased appetite—Varenicline—nicotine dependence	0.00501	0.00555	CcSEcCtD
Palonosetron—HTR3A—Ion channel transport—GABRA4—nicotine dependence	0.00499	0.0507	CbGpPWpGaD
Palonosetron—Gastrointestinal disorder—Varenicline—nicotine dependence	0.00497	0.00552	CcSEcCtD
Palonosetron—Fatigue—Varenicline—nicotine dependence	0.00497	0.00551	CcSEcCtD
Palonosetron—HTR3A—SIDS Susceptibility Pathways—CHRNB4—nicotine dependence	0.00493	0.0501	CbGpPWpGaD
Palonosetron—Constipation—Varenicline—nicotine dependence	0.00493	0.00546	CcSEcCtD
Palonosetron—Pain—Varenicline—nicotine dependence	0.00493	0.00546	CcSEcCtD
Palonosetron—Gastrointestinal pain—Varenicline—nicotine dependence	0.00471	0.00522	CcSEcCtD
Palonosetron—Body temperature increased—Varenicline—nicotine dependence	0.00455	0.00505	CcSEcCtD
Palonosetron—Abdominal pain—Varenicline—nicotine dependence	0.00455	0.00505	CcSEcCtD
Palonosetron—Hypersensitivity—Varenicline—nicotine dependence	0.00424	0.00471	CcSEcCtD
Palonosetron—Asthenia—Varenicline—nicotine dependence	0.00413	0.00458	CcSEcCtD
Palonosetron—Pruritus—Varenicline—nicotine dependence	0.00407	0.00452	CcSEcCtD
Palonosetron—Diarrhoea—Varenicline—nicotine dependence	0.00394	0.00437	CcSEcCtD
Palonosetron—CYP3A4—Xenobiotics—CYP2A7—nicotine dependence	0.00388	0.0393	CbGpPWpGaD
Palonosetron—Dizziness—Varenicline—nicotine dependence	0.00381	0.00423	CcSEcCtD
Palonosetron—Vomiting—Varenicline—nicotine dependence	0.00366	0.00406	CcSEcCtD
Palonosetron—Rash—Varenicline—nicotine dependence	0.00363	0.00403	CcSEcCtD
Palonosetron—Dermatitis—Varenicline—nicotine dependence	0.00363	0.00402	CcSEcCtD
Palonosetron—Headache—Varenicline—nicotine dependence	0.00361	0.004	CcSEcCtD
Palonosetron—Nausea—Varenicline—nicotine dependence	0.00342	0.0038	CcSEcCtD
Palonosetron—HTR3A—SIDS Susceptibility Pathways—CHRNB2—nicotine dependence	0.00329	0.0334	CbGpPWpGaD
Palonosetron—HTR3A—SIDS Susceptibility Pathways—CHRNA4—nicotine dependence	0.00299	0.0303	CbGpPWpGaD
Palonosetron—CYP2D6—Cytochrome P450 - arranged by substrate type—CYP2A7—nicotine dependence	0.00246	0.025	CbGpPWpGaD
Palonosetron—CYP2D6—Oxidation by Cytochrome P450—CYP2A7—nicotine dependence	0.00243	0.0246	CbGpPWpGaD
Palonosetron—CYP1A2—Cytochrome P450 - arranged by substrate type—CYP2A7—nicotine dependence	0.00209	0.0212	CbGpPWpGaD
Palonosetron—CYP1A2—Oxidation by Cytochrome P450—CYP2A7—nicotine dependence	0.00206	0.0209	CbGpPWpGaD
Palonosetron—CYP2D6—Phase 1 - Functionalization of compounds—CYP2A7—nicotine dependence	0.002	0.0202	CbGpPWpGaD
Palonosetron—HTR3A—Transmembrane transport of small molecules—GABRA4—nicotine dependence	0.00174	0.0176	CbGpPWpGaD
Palonosetron—CYP1A2—Phase 1 - Functionalization of compounds—CYP2A7—nicotine dependence	0.00169	0.0172	CbGpPWpGaD
Palonosetron—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP2A7—nicotine dependence	0.00161	0.0163	CbGpPWpGaD
Palonosetron—CYP3A4—Oxidation by Cytochrome P450—CYP2A7—nicotine dependence	0.00159	0.0161	CbGpPWpGaD
Palonosetron—CYP3A4—Phase 1 - Functionalization of compounds—CYP2A7—nicotine dependence	0.0013	0.0132	CbGpPWpGaD
Palonosetron—CYP2D6—Metapathway biotransformation—AKR1B10—nicotine dependence	0.00112	0.0114	CbGpPWpGaD
Palonosetron—CYP2D6—Biological oxidations—CYP2A7—nicotine dependence	0.00106	0.0108	CbGpPWpGaD
Palonosetron—CYP2D6—Metapathway biotransformation—CYP2A7—nicotine dependence	0.00105	0.0106	CbGpPWpGaD
Palonosetron—CYP1A2—Metapathway biotransformation—AKR1B10—nicotine dependence	0.000953	0.00967	CbGpPWpGaD
Palonosetron—CYP1A2—Biological oxidations—CYP2A7—nicotine dependence	0.000898	0.00911	CbGpPWpGaD
Palonosetron—CYP1A2—Metapathway biotransformation—CYP2A7—nicotine dependence	0.000886	0.00899	CbGpPWpGaD
Palonosetron—CYP3A4—Metapathway biotransformation—AKR1B10—nicotine dependence	0.000735	0.00746	CbGpPWpGaD
Palonosetron—CYP3A4—Biological oxidations—CYP2A7—nicotine dependence	0.000693	0.00703	CbGpPWpGaD
Palonosetron—CYP3A4—Metapathway biotransformation—CYP2A7—nicotine dependence	0.000684	0.00694	CbGpPWpGaD
Palonosetron—CYP2D6—Metabolism—CYP2A7—nicotine dependence	0.000181	0.00184	CbGpPWpGaD
Palonosetron—CYP1A2—Metabolism—CYP2A7—nicotine dependence	0.000154	0.00156	CbGpPWpGaD
Palonosetron—CYP3A4—Metabolism—CYP2A7—nicotine dependence	0.000119	0.0012	CbGpPWpGaD
